Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schellekens

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Methods in Enzymology|January 1, 1986
Production, purification, and characterization of rat interferon from transformed rat cellsP H van der Meide, J Wubben, K Vijverberg, et al.
Clinical and Experimental Immunology|November 1, 1989
Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibodyI Wiesenberg, P H Van der Meide, H Schellekens, et al.
Antiviral Research|January 1, 1985
The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeysP H van der Meide, N Harteveld, N Stebbing, et al.
The Journal of General Virology|June 1, 1976
Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell linesP T Allen, H Schellekens, L J Van Griensven, et al.
The Journal of General Virology|February 1, 1984
Antiviral activity of interferon in rats and the effect of immune suppressionH Schellekens, E Smiers-de Vreede, A de Reus, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
The cost-effectiveness of drug regulation: the example of thorough QT/QTc studiesJ C Bouvy, M A Koopmanschap, R R Shah, et al.
Clinical Pharmacology and Therapeutics|April 4, 2013
The cost-effectiveness of periodic safety update reports for biologicals in EuropeJ C Bouvy, H C Ebbers, H Schellekens, et al.
The Journal of General Virology|August 1, 1988
Antiviral activity of recombinant rat interferon gamma in immunologically impaired and immunosuppressed ratsV E Schijns, T H Borman, H Schellekens, et al.
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyC H Polman, F Deisenhammer, G Giovannoni, et al.
Psychosomatic Medicine|July 27, 2006
Vagal and sympathetic activity in burnouts during a mentally demanding workdayYdwine J Zanstra, Jan M H Schellekens, Cas Schaap, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Methods in Enzymology|January 1, 1986
Production, purification, and characterization of rat interferon from transformed rat cellsP H van der Meide, J Wubben, K Vijverberg, et al.
Clinical and Experimental Immunology|November 1, 1989
Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibodyI Wiesenberg, P H Van der Meide, H Schellekens, et al.
Antiviral Research|January 1, 1985
The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeysP H van der Meide, N Harteveld, N Stebbing, et al.
The Journal of General Virology|June 1, 1976
Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell linesP T Allen, H Schellekens, L J Van Griensven, et al.
The Journal of General Virology|February 1, 1984
Antiviral activity of interferon in rats and the effect of immune suppressionH Schellekens, E Smiers-de Vreede, A de Reus, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
The cost-effectiveness of drug regulation: the example of thorough QT/QTc studiesJ C Bouvy, M A Koopmanschap, R R Shah, et al.
Clinical Pharmacology and Therapeutics|April 4, 2013
The cost-effectiveness of periodic safety update reports for biologicals in EuropeJ C Bouvy, H C Ebbers, H Schellekens, et al.
The Journal of General Virology|August 1, 1988
Antiviral activity of recombinant rat interferon gamma in immunologically impaired and immunosuppressed ratsV E Schijns, T H Borman, H Schellekens, et al.
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyC H Polman, F Deisenhammer, G Giovannoni, et al.
Psychosomatic Medicine|July 27, 2006
Vagal and sympathetic activity in burnouts during a mentally demanding workdayYdwine J Zanstra, Jan M H Schellekens, Cas Schaap, et al.
Pageof 16